I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Homicsko, K.
38
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (37)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
Response and Resistance to Trametinib in MAP2K1-Mutant Trip..:
Krebs, F.S
;
Moura, B
;
Missiaglia, E
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms24054520. , 2023
Link:
https://serval.unil.ch/n..
?
2
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity res..:
Tichet, M
;
Wullschleger, S
;
Chryplewicz, A
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.immuni.2022.12.006. , 2023
Link:
https://serval.unil.ch/n..
?
3
Deep and lasting response and acquired resistance to BRAFV6..:
Anchisi, S
;
Wolfer, A
;
Bisig, B
...
info:eu-repo/semantics/altIdentifier/doi/10.1080/15384047.2023.2193116. , 2023
Link:
https://serval.unil.ch/n..
?
4
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipi..:
Homicsko, K
;
Dummer, R
;
Hoeller, C
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14092300. , 2022
Link:
https://serval.unil.ch/n..
?
5
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequen..:
Aedo-Lopez, V
;
Gérard, C.L
;
Boughdad, S
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14051162. , 2022
Link:
https://serval.unil.ch/n..
?
6
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipi..:
Homicsko, K
;
Dummer, R
;
Hoeller, C
...
ARTN 2300. , 2022
Link:
https://repository.icr.a..
?
7
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Rel..:
Gautron Moura, B
;
Gerard, C.L
;
Testart, N
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15010031. , 2022
Link:
https://serval.unil.ch/n..
?
8
First communication on the efficacy of combined 177Lutetium..:
Digklia, A
;
Boughdad, S
;
Homicsko, K
...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2022-005383. , 2022
Link:
https://serval.unil.ch/n..
?
9
Late-onset and long-lasting immune-related adverse events f..:
Ghisoni, E
;
Wicky, A
;
Bouchaab, H
...
https://boris.unibe.ch/160865/. , 2021
Link:
https://boris.unibe.ch/1..
?
10
Ovarian cancer with high-level focal ERBB2 amplification re..:
Thouvenin, L
;
Charrier, M
;
Clement, S
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.gore.2021.100787. , 2021
Link:
https://serval.unil.ch/n..
?
11
Late-onset and long-lasting immune-related adverse events f..:
Ghisoni E
;
Wicky A
;
Bouchaab H
...
info:eu-repo/semantics/altIdentifier/pmid/33865201. , 2021
Link:
http://hdl.handle.net/11..
?
12
Late-onset and long-lasting immune-related adverse events f..:
Ghisoni, E
;
Wicky, A
;
Bouchaab, H
...
info:eu-repo/semantics/altIdentifier/pmid/33865201. , 2021
Link:
http://hdl.handle.net/23..
?
13
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48..:
Krebs, F.S
;
Gérard, C
;
Wicky, A
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms21218021. , 2020
Link:
https://serval.unil.ch/n..
?
14
Mélanome localement avancé et métastatique : nouveautés [Lo..:
Huber, A
;
Latifyan, S
;
Nikolopoulou, A
...
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.695.1092. , 2020
Link:
https://serval.unil.ch/n..
?
15
Durable response to palbociclib and letrozole in ovarian ca..:
Frisone, D
;
Charrier, M
;
Clement, S
...
info:eu-repo/semantics/altIdentifier/doi/10.1080/15384047.2019.1685291. , 2020
Link:
https://serval.unil.ch/n..
1-15